Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.

Saved in:
Bibliographic Details
Title: Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
Authors: Amrein PC; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Preffer FI; Immunopathology, Massachusetts General Hospital, Boston, MA, USA., Fell G; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Attar EC; Aprea Therapeutics, Inc, Boston, MA, USA., Narayan R; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Blonquist TM; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Brunner AM; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Hobbs GS; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Hock HR; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., McAfee SL; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Moran JA; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Bergeron MK; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Foster JE; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Bertoli C; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., McGregor K; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Connolly C; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Behnan TT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Som TT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Ramos AY; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Vartanian MK; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Lombardi Story J; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Fathi AT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jul; Vol. 66 (7), pp. 1234-1244. Date of Electronic Publication: 2025 Mar 12.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40070233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Amrein+PC%22">Amrein PC</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Preffer+FI%22">Preffer FI</searchLink>; Immunopathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fell+G%22">Fell G</searchLink>; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Attar+EC%22">Attar EC</searchLink>; Aprea Therapeutics, Inc, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Narayan+R%22">Narayan R</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Blonquist+TM%22">Blonquist TM</searchLink>; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Brunner+AM%22">Brunner AM</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hobbs+GS%22">Hobbs GS</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hock+HR%22">Hock HR</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22McAfee+SL%22">McAfee SL</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moran+JA%22">Moran JA</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bergeron+MK%22">Bergeron MK</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Foster+JE%22">Foster JE</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bertoli+C%22">Bertoli C</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22McGregor+K%22">McGregor K</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+C%22">Connolly C</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Behnan+TT%22">Behnan TT</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Som+TT%22">Som TT</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ramos+AY%22">Ramos AY</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Vartanian+MK%22">Vartanian MK</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lombardi+Story+J%22">Lombardi Story J</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Neuberg+DS%22">Neuberg DS</searchLink>; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fathi+AT%22">Fathi AT</searchLink>; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Jul; Vol. 66 (7), pp. 1234-1244. <i>Date of Electronic Publication: </i>2025 Mar 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40070233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2476655
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1234
    Titles:
      – TitleFull: Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Amrein PC
      – PersonEntity:
          Name:
            NameFull: Preffer FI
      – PersonEntity:
          Name:
            NameFull: Fell G
      – PersonEntity:
          Name:
            NameFull: Attar EC
      – PersonEntity:
          Name:
            NameFull: Narayan R
      – PersonEntity:
          Name:
            NameFull: Blonquist TM
      – PersonEntity:
          Name:
            NameFull: Brunner AM
      – PersonEntity:
          Name:
            NameFull: Hobbs GS
      – PersonEntity:
          Name:
            NameFull: Hock HR
      – PersonEntity:
          Name:
            NameFull: McAfee SL
      – PersonEntity:
          Name:
            NameFull: Moran JA
      – PersonEntity:
          Name:
            NameFull: Bergeron MK
      – PersonEntity:
          Name:
            NameFull: Foster JE
      – PersonEntity:
          Name:
            NameFull: Bertoli C
      – PersonEntity:
          Name:
            NameFull: McGregor K
      – PersonEntity:
          Name:
            NameFull: Connolly C
      – PersonEntity:
          Name:
            NameFull: Behnan TT
      – PersonEntity:
          Name:
            NameFull: Som TT
      – PersonEntity:
          Name:
            NameFull: Ramos AY
      – PersonEntity:
          Name:
            NameFull: Vartanian MK
      – PersonEntity:
          Name:
            NameFull: Lombardi Story J
      – PersonEntity:
          Name:
            NameFull: Neuberg DS
      – PersonEntity:
          Name:
            NameFull: Fathi AT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1